These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6330603)

  • 21. [Experimental coronavirus encephalomyelitis in mice].
    Maĭorova LP; Konovalov GV; Ogurtsov RP; Smorodintsev AA
    Vopr Virusol; 1987; 32(1):99-105. PubMed ID: 3033910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease.
    Fleming JO; Trousdale MD; Bradbury J; Stohlman SA; Weiner LP
    Microb Pathog; 1987 Jul; 3(1):9-20. PubMed ID: 2848172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro models of demyelinating disease, XXIII: Infection by JHM virus of athymic rats.
    Sorensen O; Saravani A; Dales S
    Adv Exp Med Biol; 1987; 218():383-90. PubMed ID: 2829549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus-induced encephalomyelitis: balance between protection and immune pathology depends on the immunization schedule with spike protein S.
    Flory E; Stühler A; Barac-Latas V; Lassmann H; Wege H
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():873-9. PubMed ID: 9049333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus JHM induced demyelinating disease: specific domains on the E2-protein are associated with neurovirulence.
    Wege H; Winter J; Massa P; Dörries R; ter Meulen V
    Adv Exp Med Biol; 1987; 218():307-20. PubMed ID: 2449042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.
    Sorensen O; Dugre R; Percy D; Dales S
    Infect Immun; 1982 Sep; 37(3):1248-60. PubMed ID: 6290393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal antibody-modulated MHV-JHM infection in C57BL/6 and BALB/c mice.
    Perlman S; Schelper R; Ries D
    Adv Exp Med Biol; 1987; 218():297-305. PubMed ID: 2829543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapsing encephalomyelitis following transfer of partial immunity to JHM virus.
    Shubin RA; Sussman MA; Fleming JO; Stohlman SA
    Microb Pathog; 1990 May; 8(5):305-14. PubMed ID: 1977071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats.
    Sorensen O; Perry D; Dales S
    Arch Neurol; 1980 Aug; 37(8):478-84. PubMed ID: 6251790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptation of coronavirus JHM to persistent infection of murine sac(-) cells.
    Baybutt HN; Wege H; Carter MJ; ter Meulen V
    J Gen Virol; 1984 May; 65 ( Pt 5)():915-24. PubMed ID: 6327888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis.
    Watanabe R; Wege H; ter Meulen V
    Nature; 1983 Sep 8-14; 305(5930):150-3. PubMed ID: 6310411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronavirus JHM OMP1 pathogenesis in owl monkey CNS and coronavirus infection of owl monkey CNS via peripheral routes.
    Cabirac GF; Soike KF; Butunoi C; Hoel K; Johnson S; Cai GY; Murray RS
    Adv Exp Med Biol; 1993; 342():347-52. PubMed ID: 8209752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus-JHM-induced demyelinating encephalomyelitis in rats. Analysis of the intrathecal immune response.
    Dörries R; Schwender S; Wege H; Harms H; Watanabe R; ter Meulen V
    Ann N Y Acad Sci; 1988; 540(1):663-4. PubMed ID: 2849910
    [No Abstract]   [Full Text] [Related]  

  • 34. Coronavirus infection and demyelination. Development of inflammatory lesions in Lewis rats.
    Wege H; Schluesener H; Meyermann R; Barac-Latas V; Suchanek G; Lassmann H
    Adv Exp Med Biol; 1998; 440():437-44. PubMed ID: 9782312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis.
    Glass WG; Hickey MJ; Hardison JL; Liu MT; Manning JE; Lane TE
    J Immunol; 2004 Apr; 172(7):4018-25. PubMed ID: 15034013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro models of demyelinating disease. XVII. The infectious process in athymic rats inoculated with JHM virus.
    Sorensen O; Saravani A; Dales S
    Microb Pathog; 1987 Feb; 2(2):79-90. PubMed ID: 2853273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant vaccinia viruses which express MHV-JHM proteins: protective immune response and the influence of vaccination on coronavirus-induced encephalomyelitis.
    Flory E; Stühler A; Wege H; Siddell S; Wege H
    Adv Exp Med Biol; 1993; 342():401-6. PubMed ID: 8209761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further observations on coronavirus infection of primate CNS.
    Murray RS; Cai GY; Soike KF; Cabirac GF
    J Neurovirol; 1997 Feb; 3(1):71-5. PubMed ID: 9147824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus JHM infection of rats as a model for virus induced demyelinating encephalomyelitis.
    Wege H; Watanabe R; ter Meulen V
    Prog Clin Biol Res; 1984; 146():13-22. PubMed ID: 6201885
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic central nervous system demyelination in mice after JHM virus infection.
    Stohlman SA; Weiner LP
    Neurology; 1981 Jan; 31(1):38-44. PubMed ID: 6256683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.